Hypersensitivity reaction in a child due to lamotrigine

Pediatr Dermatol. 1999 Jan-Feb;16(1):46-9. doi: 10.1046/j.1525-1470.1999.99014.x.

Abstract

Lamotrigine is an anticonvulsant with a broad spectrum of activity that has been approved in the United States for use in adults with either partial or generalized seizures. This drug is being widely prescribed by pediatricians and neurologists because it is effective in children with idiopathic, resistant, generalized seizures and does not impair cognition. As with other anticonvulsants, a hypersensitivity syndrome has been described. Anticonvulsant hypersensitivity syndrome consists of the hallmark features of fever, rash, and lymphadenopathy. We report the first case of hypersensitivity syndrome in a child due to lamotrigine in which we believe the coadministration of valproic acid increased the duration of the reaction. Our patient had a high spiking fever, generalized morbilliform eruption, facial edema, lymphadenopathy, eosinophilia, atypical lymphocytosis, and an elevation in his liver function tests. The syndrome resolved with the discontinuation of the medication. Anticonvulsant hypersensitivity syndrome may occur with the administration of lamotrigine. Variable presentations may be seen, as hypersensitivity syndromes may be multisystem in nature. The prompt recognition of the signs and symptoms of this condition allows an accurate diagnosis so that the drug may be discontinued and other anticonvulsant treatment options instituted.

Publication types

  • Case Reports

MeSH terms

  • Anticonvulsants / adverse effects*
  • Child, Preschool
  • Diagnosis, Differential
  • Drug Eruptions / diagnosis*
  • Epilepsy, Tonic-Clonic / drug therapy*
  • Humans
  • Lamotrigine
  • Male
  • Syndrome
  • Triazines / adverse effects*
  • Valproic Acid / therapeutic use

Substances

  • Anticonvulsants
  • Triazines
  • Valproic Acid
  • Lamotrigine